{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:07:11Z","timestamp":1790874431992,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272200900008C"],"award-info":[{"award-number":["HHSN272200900008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jconrel.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T20:48:25Z","timestamp":1446842905000},"page":"64-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccination"],"prefix":"10.1016","volume":"223","author":[{"given":"Hardeep S.","family":"Oberoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M.","family":"Yorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Morasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay T.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.11.006_bb0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems","volume":"10","author":"Gar\u00e7on","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jconrel.2014.05.060","article-title":"Buccal and sublingual vaccine delivery","volume":"190","author":"Kraan","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0015","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.4049\/jimmunol.0803568","article-title":"CCR7-CCL19\/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination","volume":"182","author":"Song","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/mi.2013.45","article-title":"Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells","volume":"7","author":"Hervouet","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4110\/in.2013.13.3.81","article-title":"Sublingual delivery of vaccines for the induction of mucosal immunity","volume":"13","author":"Shim","year":"2013","journal-title":"Immune Netw."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0030","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/j.1365-2222.2008.03056.x","article-title":"Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route","volume":"38","author":"Lombardi","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-3083.2007.01975.x","article-title":"Sublingual \u2018oral tolerance\u2019 induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells","volume":"66","author":"Sun","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0040","doi-asserted-by":"crossref","first-page":"e1003875","DOI":"10.1371\/journal.ppat.1003875","article-title":"Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection","volume":"10","author":"Maroof","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0050","doi-asserted-by":"crossref","first-page":"138ra179","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0055","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0060","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.04.002","article-title":"Comparative study of Pluronic(\u00ae) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats","volume":"449","author":"Chen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0070","first-page":"3151","article-title":"Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake","volume":"6","author":"Li","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0075","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1021\/jp0687302","article-title":"PEO\u2013PPO block copolymer vectors do not interact directly with DNA but with lipid membranes","volume":"111","author":"Gau-Racine","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0378-5173(92)90331-U","article-title":"Liposome leakage and blood circulation: comparison of adsorbed block copolymers with covalent attachment of PEG","volume":"88","author":"Woodle","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0085","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1021\/la990288+","article-title":"Effect of PEO\u2013PPO\u2013PEO triblock copolymers on structure and stability of phosphatidylcholine liposomes","volume":"15","author":"Johnsson","year":"1999","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-5173(88)90255-4","article-title":"Poloxamer sorption on liposomes: comparison with polystyrene latex and influence on solute efflux","volume":"48","author":"Jamshaid","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0095","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1021\/bi048373q","article-title":"Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers","volume":"44","author":"Demina","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0169-409X(00)00120-4","article-title":"Mucoadhesive nanoparticulate systems for peptide drug delivery","volume":"47","author":"Takeuchi","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0105","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1023\/A:1016009313548","article-title":"Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes","volume":"13","author":"Takeuchi","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-5173(94)90218-6","article-title":"Interactions between liposomes and chitosan","volume":"101","author":"Henriksen","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","article-title":"Effect of chitosan on epithelial cell tight junctions","volume":"21","author":"Smith","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0120","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1016\/j.bmcl.2008.09.060","article-title":"The \u2018ethereal\u2019 nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics","volume":"18","author":"Bazin","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpb.2006.06.003","article-title":"Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs","volume":"64","author":"Sezgin","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0927-7757(94)03028-X","article-title":"Poly(ethylene oxide)poly(propylene oxide)poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling","volume":"96","author":"Alexandridis","year":"1995","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0135","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","article-title":"Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus","volume":"6","author":"Cu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-5173(91)90134-A","article-title":"The effect of poloxamer-407 on liposome stability and targeting to bone marrow: comparison with polystyrene microspheres","volume":"68","author":"Moghimi","year":"1991","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0150","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.biomaterials.2004.07.038","article-title":"An investigation on the physicochemical properties of chitosan\/DNA polyelectrolyte complexes","volume":"26","author":"Liu","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0155","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1023\/A:1012160102740","article-title":"Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement","volume":"14","author":"Schipper","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0169-409X(97)00121-X","article-title":"Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery","volume":"31","author":"Bromberg","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0165","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1016\/S0264-410X(03)00143-9","article-title":"Regional, but not systemic recruitment\/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity","volume":"21","author":"Sang","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0170","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/1574-695X.12010","article-title":"Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice","volume":"66","author":"Jain-Gupta","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/387023","article-title":"Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine","volume":"2013","author":"Li","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2796.2012.02556.x","article-title":"Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches","volume":"272","author":"Valenta","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2011.01.007","article-title":"A comprehensive study in triblock copolymer membrane interaction","volume":"151","author":"Pembouong","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1872208311206030200","article-title":"Poloxamer 188 (p188) as a membrane resealing reagent in biomedical applications","volume":"6","author":"Moloughney","year":"2012","journal-title":"Recent Pat. Biotechnol."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0195","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.vaccine.2008.02.058","article-title":"Surface modified liposomes for nasal delivery of DNA vaccine","volume":"26","author":"Khatri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0200","first-page":"2523","article-title":"Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties","volume":"7","author":"Gradauer","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2008.11.013","article-title":"Chitosan\u2013aprotinin coated liposomes for oral peptide delivery: development, characterisation and in vivo evaluation","volume":"370","author":"Werle","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.colsurfb.2009.01.010","article-title":"Chitosan-coated liposomes for delivery to lungs by nebulisation","volume":"71","author":"Zaru","year":"2009","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2015.11.006_bb0215","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0225","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0230","first-page":"586","article-title":"Buccal mucosa: a gifted choice for systemic drug delivery","volume":"3","author":"Parthasarathy","year":"2011","journal-title":"Int. J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2015.11.006_bb0235","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1021\/bm800276d","article-title":"Why is chitosan mucoadhesive?","volume":"9","author":"Sogias","year":"2008","journal-title":"Biomacromolecules"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915302303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915302303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:46:12Z","timestamp":1790873172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915302303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":47,"alternative-id":["S0168365915302303"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.006","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccination","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}